Northwestern Mutual Wealth Management
REGN icon

Northwestern Mutual Wealth Management’s Regeneron Pharmaceuticals REGN Stock Holding History

Northwestern Mutual Wealth Management’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.13M Sell
4,053
-138
-3% -$106K ﹤0.01% 956
2025
Q4 		$3.24M Buy
4,191
+1,015
+32% +$689K ﹤0.01% 907
2025
Q3 		$1.79M Sell
3,176
-658
-17% -$372K ﹤0.01% 1034
2025
Q2 		$2.01M Sell
3,834
-299
-7% -$167K ﹤0.01% 938
2025
Q1 		$2.62M Buy
4,133
+297
+8% +$204K ﹤0.01% 836
2024
Q4 		$2.73M Sell
3,836
-133
-3% -$112K ﹤0.01% 771
2024
Q3 		$4.17M Buy
3,969
+148
+4% +$165K ﹤0.01% 659
2024
Q2 		$4.02M Buy
3,821
+536
+16% +$520K ﹤0.01% 638
2024
Q1 		$3.16M Sell
3,285
-470
-13% -$447K ﹤0.01% 676
2023
Q4 		$3.3M Buy
3,755
+86
+2% +$70.8K ﹤0.01% 636
2023
Q3 		$3.02M Buy
3,669
+49
+1% +$38.5K ﹤0.01% 618
2023
Q2 		$2.6M Sell
3,620
-6
-0.2% -$4.63K ﹤0.01% 646
2023
Q1 		$2.98M Sell
3,626
-241
-6% -$182K ﹤0.01% 592
2022
Q4 		$2.79M Buy
3,867
+188
+5% +$139K ﹤0.01% 587
2022
Q3 		$2.54M Sell
3,679
-201
-5% -$127K ﹤0.01% 558
2022
Q2 		$2.29M Buy
3,880
+698
+22% +$454K ﹤0.01% 589
2022
Q1 		$2.22M Sell
3,182
-483
-13% -$306K ﹤0.01% 616
2021
Q4 		$2.31M Sell
3,665
-167
-4% -$103K ﹤0.01% 583
2021
Q3 		$2.32M Buy
3,832
+669
+21% +$415K ﹤0.01% 551
2021
Q2 		$1.77M Buy
3,163
+283
+10% +$143K ﹤0.01% 588
2021
Q1 		$1.36M Buy
2,880
+360
+14% +$175K ﹤0.01% 611
2020
Q4 		$1.22M Sell
2,520
-19
-0.7% -$10.3K ﹤0.01% 593
2020
Q3 		$1.42M Buy
2,539
+182
+8% +$110K ﹤0.01% 501
2020
Q2 		$1.47M Buy
2,357
+205
+10% +$116K ﹤0.01% 463
2020
Q1 		$1.05M Sell
2,152
-682
-24% -$281K ﹤0.01% 469
2019
Q4 		$1.06M Buy
2,834
+255
+10% +$85.8K ﹤0.01% 506
2019
Q3 		$715K Buy
2,579
+778
+43% +$230K ﹤0.01% 554
2019
Q2 		$564K Buy
1,801
+132
+8% +$43.9K ﹤0.01% 597
2019
Q1 		$685K Buy
1,669
+18
+1% +$7.41K ﹤0.01% 530
2018
Q4 		$617K Buy
1,651
+202
+14% +$73.9K ﹤0.01% 514
2018
Q3 		$586K Sell
1,449
-126
-8% -$48K ﹤0.01% 521
2018
Q2 		$543K Sell
1,575
-34
-2% -$10.6K ﹤0.01% 519
2018
Q1 		$554K Sell
1,609
-182
-10% -$63.3K ﹤0.01% 498
2017
Q4 		$673K Buy
1,791
+40
+2% +$16.2K ﹤0.01% 450
2017
Q3 		$783K Buy
1,751
+69
+4% +$32.8K 0.01% 397
2017
Q2 		$825K Sell
1,682
-74
-4% -$32.4K 0.01% 381
2017
Q1 		$680K Buy
1,756
+328
+23% +$122K 0.01% 395
2016
Q4 		$525K Buy
+1,428
New +$543K 0.01% 441
2016
Q3 		– Sell
-1,070
Closed -$373K – 1224
2016
Q2 		$373K Buy
1,070
+304
+40% +$117K 0.01% 459
2016
Q1 		$276K Buy
766
+339
+79% +$140K ﹤0.01% 498
2015
Q4 		$232K Sell
427
-5
-1% -$2.71K ﹤0.01% 485
2015
Q3 		$201K Sell
432
-1,406
-76% -$755K ﹤0.01% 486
2015
Q2 		$938K Sell
1,838
-1,528
-45% -$746K 0.02% 260
2015
Q1 		$1.52M Sell
3,366
-197
-6% -$83.5K 0.04% 213
2014
Q4 		$1.46M Sell
3,563
-51
-1% -$20.1K 0.05% 216
2014
Q3 		$1.3M Sell
3,614
-8
-0.2% -$2.68K 0.05% 209
2014
Q2 		$1.02M Buy
3,622
+356
+11% +$106K 0.04% 217
2014
Q1 		$981K Buy
3,266
+151
+5% +$46.5K 0.04% 213
2013
Q4 		$857K Buy
3,115
+3,105
+31,050% +$893K 0.04% 217
2013
Q3 		$3K Buy
+10
New +$2.63K ﹤0.01% 1116

Other funds holding REGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Northwestern Mutual Wealth Management's REGN Position: Q1 2026 in Review

Northwestern Mutual Wealth Management reduced its Regeneron Pharmaceuticals (REGN) stake by 3.3% in Q1 2026, selling an estimated $106K and leaving 4,053 shares worth $3.13M. The position accounts for ﹤0.01% of the portfolio, ranked #956.

Northwestern Mutual Wealth Management first reported a position in REGN in Q3 2013 and has held it in 50 quarters since. The position peaked at $4.17M in Q3 2024. 1,393 funds tracked by Wall St. Rank hold REGN as of Q1 2026.

  • Northwestern Mutual Wealth Management held 4,053 shares of Regeneron Pharmaceuticals worth $3.13M as of Q1 2026.
  • Northwestern Mutual Wealth Management sold 138 Regeneron Pharmaceuticals shares in Q1 2026, an estimated $106K.
  • Regeneron Pharmaceuticals made up ﹤0.01% of Northwestern Mutual Wealth Management's portfolio in Q1 2026, its #956 holding.
  • Northwestern Mutual Wealth Management first reported a position in Regeneron Pharmaceuticals in Q3 2013 and has held it in 50 quarters since.
  • Northwestern Mutual Wealth Management's Regeneron Pharmaceuticals position peaked at $4.17M in Q3 2024.
  • 1,393 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2026.

Based on Northwestern Mutual Wealth Management's 13F filing for Q1 2026, filed 7 May 2026.